Without improvements at both ends of the pitch, Spurs' current trajectory suggests it could be seen as a year of regression rather than progress.

Safety profile of lutetium-177 in patients with impaired renal function: A retrospective analysis of adverse events in mCRPC treatment. Dr. Saylani highlighted that Lutetium-177 vipivotide tetraxetan ...